Glacier Bancorp (NYSE:GBCI) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Glacier Bancorp (NYSE:GBCI) reported Q2 2026 revenue of $317.5 million, up 30.7% year over year but below Wall Street estimates. Non-GAAP earnings were $0.76 per share, matching consensus. The article also cites TBVPS rising from $18.26 to $21.81 over two years and consensus TBVPS growth to $24.30 in 12 months.

Original reporting
Published Jul 23, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 9:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Glacier Bancorp (NYSE:GBCI) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Decision brief

The 30-second read

$GBCIBearishMed
01

Why it matters

Revenue came in below analyst estimates while non-GAAP EPS matched consensus; TBVPS growth is described as accelerating recently but still below the next-12-month consensus growth rate.

02

Market read

Traders can reassess near-term expectations for revenue generation versus consensus, given the explicit revenue miss and the described flat post-results stock reaction.

03

What to watch

The text emphasizes net interest income dominance (84.7% of revenue) but does not provide NII guidance or deposit/loan yield details, which are key to judging whether the revenue miss is recurring.

Relevance 6/10Novelty 5/10Timing: after-hours/after-results reaction described as stock flat at $50.63 immediately following results

Background

The article frames Glacier Bancorp’s Q2 CY2026 results around revenue growth, net interest income dependence, and tangible book value per share (TBVPS) trends.

Company-level read

Ticker impact

$GBCIBearishMedium confidence
Context

Glacier Bancorp reported Q2 CY2026 revenue of $317.5M, up 30.7% YoY, but below Wall Street estimates, with non-GAAP EPS $0.76 in line.

Expected impact

Near-term downside bias or limited upside until management provides a clearer revenue outlook or NII/fee trajectory.

Evidence & confidence

The article’s actionable datapoint is the revenue miss versus estimates; EPS is in line, and the stock is described as flat immediately after results, suggesting the market reaction may be muted but not bullish.

Market effects

A regional bank revenue miss despite strong YoY growth reinforces that net interest income and fee mix remain sensitive to expectations.

Limited, as the article is company-specific to Glacier Bancorp’s western-state footprint.

Low, no cross-border or macro policy linkage beyond general regional banking dynamics.

Counterpoint

The 30.7% YoY revenue growth and in-line $0.76 non-GAAP EPS suggest fundamentals may be improving, and the miss could be timing or estimate-related rather than deterioration.

Key entities

  • Glacier Bancorp

    Regional banking company reporting Q2 CY2026 revenue and non-GAAP EPS versus analyst expectations.

Related articles

$GBCIMed

GLACIER BANCORP, INC. (GBCI): Results of Operations and Financial Condition

GLACIER BANCORP, INC. (GBCI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gbci-06302026xex991.htm EX-99.1 Document NEWS RELEASE July 23, 2026 FOR IMMEDIATE RELEASE CONTACT: Randall M. Chesler, CEO (406) 751-4722 Ron J. Copher, CFO (406) 751-7706 GLACIER BANCORP, INC. ANNOUNCES RESULTS FOR THE QUARTER AND PERIOD ENDED JUNE 30, 2026 2nd Quarter

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.